Citadel Advisors - MOLECULAR TEMPLATES INC ownership

MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 80 filers reported holding MOLECULAR TEMPLATES INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MOLECULAR TEMPLATES INC
ValueSharesWeighting
Q2 2022$114,000
-19.7%
125,425
+204.1%
0.00%
Q1 2022$142,000
+31.5%
41,239
+49.4%
0.00%
Q4 2021$108,000
+0.9%
27,600
+72.5%
0.00%
Q3 2021$107,000
-31.4%
16,000
-19.6%
0.00%
Q2 2021$156,000
-72.0%
19,900
-55.0%
0.00%
Q1 2021$557,000
-36.4%
44,183
-52.6%
0.00%
Q4 2020$876,000
+31.1%
93,242
+52.5%
0.00%
Q3 2020$668,000
+13.4%
61,147
+43.3%
0.00%
Q2 2020$589,000
+430.6%
42,680
+221.2%
0.00%
Q2 2019$111,000
+158.1%
13,287
+24.9%
0.00%
Q4 2018$43,000
-46.9%
10,637
-8.7%
0.00%
Q3 2017$81,00011,6460.00%
Other shareholders
MOLECULAR TEMPLATES INC shareholders Q1 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,122,991$23,183,00021.86%
Consonance Capital Management LP 1,736,012$18,957,0002.31%
Endurant Capital Management LP 422,787$4,617,0001.36%
BVF INC/IL 2,149,057$23,468,0001.28%
Monashee Investment Management LLC 502,000$5,482,0001.18%
Knoll Capital Management, LLC 113,905$1,244,0001.02%
Parkman Healthcare Partners LLC 267,938$2,926,0000.78%
Bellevue Group AG 5,021,996$54,840,0000.76%
KINGDON CAPITAL MANAGEMENT, L.L.C. 477,536$5,215,0000.59%
Abingworth LLP 200,000$2,180,0000.47%
View complete list of MOLECULAR TEMPLATES INC shareholders